person · Reporting owner
FRIEDMAN BENZION ABRAHAM
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cell Source, Inc.CLCS · Entity 9600 | Director · 10% owner | June 30, 2021 | July 07, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cell Source, Inc.
Report date June 30, 2021 · Filed July 07, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 4,408,184 |
Reported balance
After 2021-06-30 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2021-06-30 · Other · Acquired 19,440 · Balance 4,408,184 F1: Issued as payment-in-kind dividend on Series A Convertible Preferred Stock. F2: Owned by a company wholly owned by the wife of the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued as payment-in-kind dividend on Series A Convertible Preferred Stock.
F2: Owned by a company wholly owned by the wife of the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2021 Filed Jul 7, 2021 16:52 UTC | Cell Source, Inc. CLCS · Entity 9600 | OtherCommon Stock | 19,440 | $0.75 | $14,580.00 |
DisclosureSEC source: 0001493152-21-016319 · ownership.xml · nonDerivative · entry 1 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,408,184 F1 · kind: Issued as payment-in-kind dividend on Series A Convertible Preferred Stock. F2 · ownership.nature: Owned by a company wholly owned by the wife of the reporting person. Read SEC document |
| December 29, 2020 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | OtherCommon Stock | 19,672 | $0.75 | $14,754.00 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · nonDerivative · entry 7 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,471,200 F1 · kind: Issued as payment-in-kind dividend on Series A Convertible Preferred Stock. F2 · ownership.nature: Owned by a company wholly owned by the wife of the reporting person. Read SEC document |
| August 20, 2020 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | GrantDirector Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · derivative · entry 12 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2025-08-19 F2 · ownership.nature: Owned by a company wholly owned by the wife of the reporting person. Read SEC document |
| August 20, 2020 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · derivative · entry 11 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300,000 shares Expires 2025-08-19 Read SEC document |
| August 19, 2020 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | GrantDirector Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · derivative · entry 10 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2025-08-19 Read SEC document |
| June 30, 2020 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | OtherCommon Stock | 19,547 | $0.75 | $14,660.25 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · nonDerivative · entry 6 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,451,438 F1 · kind: Issued as payment-in-kind dividend on Series A Convertible Preferred Stock. F2 · ownership.nature: Owned by a company wholly owned by the wife of the reporting person. Read SEC document |
| December 31, 2019 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | OtherCommon Stock | 25,675 | $0.75 | $19,256.25 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · nonDerivative · entry 5 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,431,891 F1 · kind: Issued as payment-in-kind dividend on Series A Convertible Preferred Stock. F2 · ownership.nature: Owned by a company wholly owned by the wife of the reporting person. Read SEC document |
| June 26, 2019 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | OtherCommon Stock | 5,356 | $0.75 | $4,017.00 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · nonDerivative · entry 4 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,406,216 F1 · kind: Issued as payment-in-kind dividend on Series A Convertible Preferred Stock. F2 · ownership.nature: Owned by a company wholly owned by the wife of the reporting person. Read SEC document |
| May 07, 2019 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | GrantSeries A Convertible Preferred Stock · Derivative | 31,553 | $7.50 Strike: $0.75 | $236,647.50 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · derivative · entry 9 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 31,553 Underlying: Common Stock · 315,530 shares Expires not disclosed F3 · derivative.expiration_date: The Series A Convertible Preferred Stock has no expiration date. F2 · ownership.nature: Owned by a company wholly owned by the wife of the reporting person. Read SEC document |
| December 31, 2018 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | OtherCommon Stock | 5,444 | $0.75 | $4,083.00 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · nonDerivative · entry 3 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,400,860 F1 · kind: Issued as payment-in-kind dividend on Series A Convertible Preferred Stock. F2 · ownership.nature: Owned by a company wholly owned by the wife of the reporting person. Read SEC document |
| August 21, 2018 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | OtherCommon Stock | 6,672 | $0.75 | $5,004.00 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · nonDerivative · entry 2 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,395,416 F1 · kind: Issued as payment-in-kind dividend on Series A Convertible Preferred Stock. F2 · ownership.nature: Owned by a company wholly owned by the wife of the reporting person. Read SEC document |
| December 04, 2017 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | OtherCommon Stock | 5,400 | $0.75 | $4,050.00 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · nonDerivative · entry 1 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,388,744 F1 · kind: Issued as payment-in-kind dividend on Series A Convertible Preferred Stock. F2 · ownership.nature: Owned by a company wholly owned by the wife of the reporting person. Read SEC document |
| July 26, 2017 Filed Jun 10, 2021 17:50 UTC | Cell Source, Inc. CLCS · Entity 9600 | GrantSeries A Convertible Preferred Stock · Derivative | 12,000 | $15.00 Strike: $0.75 | $180,000.00 |
DisclosureSEC source: 0001493152-21-013992 · ownership.xml · derivative · entry 8 FRIEDMAN BENZION ABRAHAM · CIK 0001638415 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 43,553 Underlying: Common Stock · 120,000 shares Expires not disclosed F4 · price: The reporting person was issued 12,000 shares of Series A Convertible Preferred Stock and a note in the principal amount of $180,000 for an aggregate purchase price of $180,000 F3 · derivative.expiration_date: The Series A Convertible Preferred Stock has no expiration date. F2 · ownership.nature: Owned by a company wholly owned by the wife of the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.